Christophe Jean
Patrimonio netto: 1 M $ in data 30/09/2026
Patrimonio netto: 1 M $ in data 30/09/2026
Christophe R. Jean fa parte del consiglio di amministrazione di Rhythm Pharmaceuticals, Inc. e di European Biopharmaceutical Enterprises. In passato Jean ha ricoperto le posizioni di EVP-Strategy & Business Development presso Ipsen SA e EVP-Strategy & Business Development presso Ipsen Pharma SAS (una filiale di Ipsen SA), Head-Europe, Middle East & Africa presso Novartis AG, Presidente-Europe, Middle East & Africa presso Novartis Pharmaceuticals Corp. e Financial Controller & Head-Finance presso Ciba-Geigy AG (entrambe filiali di Novartis AG), Chairman & Chief Executive Officer presso Pierre Fabre Mdicament SAS e Managing Director presso Ipsen Pharma SA. Jean ha ricevuto un MBA dalla Harvard Business School.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 24/06/2026 | 11.712 ( 0,02% ) | 1 M $ | 30/09/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 01/04/2015 |
B Cell Design SAS
B Cell Design SAS Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops innovative products and breakthrough therapeutic concepts for pharma industries | Direttore/Membro del Consiglio | - |
eureKING SA
eureKING SA Financial ConglomeratesFinance Operates as a special purpose acquisition company | Fondatore | - |
European Biopharmaceutical Enterprises
European Biopharmaceutical Enterprises BiotechnologyHealth Technology Develops biological products | Direttore/Membro del Consiglio | - |
Back to Basics, Inc.
Back to Basics, Inc. Food RetailRetail Trade Engages in retails sales of vitamins and supplement products | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
| IPSEN | Direttore operativo | 01/11/2013 |
Exonhit
Exonhit Pharmaceuticals: MajorHealth Technology Develops and manufactures novel pharmaceuticals | Direttore/Membro del Consiglio | 20/12/2012 |
Tercica, Inc.
Tercica, Inc. Pharmaceuticals: MajorHealth Technology Develops new therapeutics for endocrine system disorders | Direttore/Membro del Consiglio | 01/01/2008 |
Pierre Fabre Group
Pierre Fabre Group Household/Personal CareConsumer Non-Durables Manufactures cosmetics and skincare products | Corporate Officer/Principal | 01/01/2002 |
| ░░░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 19 |
|---|---|
Tercica, Inc.
Tercica, Inc. Pharmaceuticals: MajorHealth Technology Develops new therapeutics for endocrine system disorders | Health Technology |
Ipsen SA
Ipsen SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Rhythm Pharmaceuticals, Inc.
Rhythm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies peptide therapeutics for rare neuroendocrine diseases | Health Technology |
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Ciba-Geigy AG
Ciba-Geigy AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Pierre Fabre Médicament SAS
Pierre Fabre Médicament SAS Pharmaceuticals: OtherHealth Technology Manufactures cosmetics and pharmaceutical products | Health Technology |
Exonhit
Exonhit Pharmaceuticals: MajorHealth Technology Develops and manufactures novel pharmaceuticals | Health Technology |
Ipsen Pharma SA
Ipsen Pharma SA Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Keosys SAS
Keosys SAS Medical/Nursing ServicesHealth Services Provides medical imaging technology and associated services | Health Services |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
European Biopharmaceutical Enterprises
European Biopharmaceutical Enterprises BiotechnologyHealth Technology Develops biological products | Health Technology |
Ipsen Pharma SAS
Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Allergan GI Corp.
Allergan GI Corp. BiotechnologyHealth Technology Develops peptide therapeutics for the treatment of gastrointestinal diseases | Health Technology |
B Cell Design SAS
B Cell Design SAS Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops innovative products and breakthrough therapeutic concepts for pharma industries | Commercial Services |
Eurobio-Scientific SA
Eurobio-Scientific SA Medical SpecialtiesHealth Technology Develops and distributes medical diagnosis tool kits | Health Technology |
Back to Basics, Inc.
Back to Basics, Inc. Food RetailRetail Trade Engages in retails sales of vitamins and supplement products | Retail Trade |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pierre Fabre Group
Pierre Fabre Group Household/Personal CareConsumer Non-Durables Manufactures cosmetics and skincare products | Consumer Non-Durables |
eureKING SA
eureKING SA Financial ConglomeratesFinance Operates as a special purpose acquisition company | Finance |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale